ALOXI Trademark

Trademark Overview

On Monday, May 29, 2023, a trademark application was filed for ALOXI with the United States Patent and Trademark Office. The USPTO has given the ALOXI trademark a serial number of 98017461. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, May 6, 2025. This trademark is owned by Ingenus Pharmaceuticals, LLC. The ALOXI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for anti-emetic purposes
aloxi

General Information

Serial Number98017461
Word MarkALOXI
Filing DateMonday, May 29, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, May 6, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 11, 2025

Trademark Statements

Goods and ServicesPharmaceutical preparations for anti-emetic purposes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, June 7, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameIngenus Pharmaceuticals, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressOrlando, FL 32839
Party NameIngenus Pharmaceuticals, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressOrlando, FL 32839

Trademark Events

Event DateEvent Description
Wednesday, February 21, 2024ASSIGNED TO EXAMINER
Thursday, June 1, 2023NEW APPLICATION ENTERED
Wednesday, June 7, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 22, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, February 22, 2024NON-FINAL ACTION WRITTEN
Thursday, February 22, 2024NON-FINAL ACTION E-MAILED
Sunday, August 18, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, August 18, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 17, 2024LETTER OF SUSPENSION E-MAILED
Tuesday, September 17, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, September 17, 2024SUSPENSION LETTER WRITTEN
Monday, February 3, 2025TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Sunday, May 5, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Sunday, May 5, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Sunday, August 18, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 10, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 10, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 14, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, February 10, 2025ASSIGNED TO LIE
Tuesday, February 18, 2025LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, March 5, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 11, 2025PUBLISHED FOR OPPOSITION
Tuesday, March 11, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 6, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Related Keywords

aloxi purposes emetic anti preparations pharmaceutical